Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
naphazoline | alpha-1a adrenergic receptor | small molecule | NA | drugbank | Vascular constriction (function)[MeSHID:D014661] Nose[MeSHID:D009666] Vision[MeSHID:D014785] Eye[MeSHID:D005123] Hyperemia[MeSHID:D006940] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pruritus[MeSHID:D011537] |
NA | approved,investigational | agonist |
naphazoline | alpha-2a adrenergic receptor | small molecule | NA | drugbank | Vascular constriction (function)[MeSHID:D014661] Nose[MeSHID:D009666] Vision[MeSHID:D014785] Eye[MeSHID:D005123] Hyperemia[MeSHID:D006940] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pruritus[MeSHID:D011537] |
NA | approved,investigational | agonist |
naphazoline | dopamine d2 receptor | NA | Successful target | TTD , DGIDB | Vascular constriction (function)[MeSHID:D014661] Nose[MeSHID:D009666] Vision[MeSHID:D014785] Eye[MeSHID:D005123] Hyperemia[MeSHID:D006940] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pruritus[MeSHID:D011537] |
0.18 | approved | unknown |
click here to return to the previous page |